Denteric Commences a Phase I Safety Study in Patients with Early Alzheimer's Disease
MELBOURNE, Australia, May 28, 2026 /PRNewswire/ -- Denteric today announced the commencement of participant recruitment for a Phase I clinical study of its first-in-class therapy for Alzheimer's disease. Alzheimer's disease remains one of the greatest medical challenges of our time and...
MELBOURNE, Australia, May 28, 2026 /PRNewswire/ -- Denteric today announced the commencement of participant recruitment for a Phase I clinical study of its first-in-class therapy for Alzheimer's disease. Alzheimer's disease remains one of the greatest medical challenges of our time and...
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.